These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 11026642
1. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats. Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P. J Cardiovasc Pharmacol; 2000 Oct; 36(4):428-37. PubMed ID: 11026642 [Abstract] [Full Text] [Related]
2. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Yard B, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P. Transplantation; 1999 Sep 27; 68(6):739-46. PubMed ID: 10515373 [Abstract] [Full Text] [Related]
3. Improved recovery following posttransplant acute renal failure in rat renal isografts with an oral endothelin-A receptor antagonist. Braun C, Vetter S, Conzelmann T, Schaub M, Kirchengast M, van der Woude FJ, Rohmeiss P. Exp Nephrol; 2000 Sep 27; 8(4-5):283-90. PubMed ID: 10940728 [Abstract] [Full Text] [Related]
4. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection. Knoll T, Oltersdorf J, Göttmann U, Schaub M, Michel MS, Kirchengast M, van der Woude FJ, Rohmeiss P, Braun C. Transpl Int; 2003 Jun 27; 16(6):425-9. PubMed ID: 12819874 [Abstract] [Full Text] [Related]
5. Endothelin-1, endothelin-3 and their receptors (endothelin(A) and endothelin(B)) in chronic renal transplant rejection in rats. Deng DX, Jiang J, Garcia B, Zhong R, Chakrabarti S. Transpl Int; 2000 Jun 27; 13(3):175-82. PubMed ID: 10935699 [Abstract] [Full Text] [Related]
6. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin). Braun C, Schultz M, Fang L, Schaub M, Back WE, Herr D, Laux V, Rohmeiss P, Schnuelle P, van der Woude FJ. Transplantation; 2001 Jul 27; 72(2):209-15. PubMed ID: 11477340 [Abstract] [Full Text] [Related]
7. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model. Adams J, Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR. Nephrol Dial Transplant; 2002 May 27; 17(5):780-7. PubMed ID: 11981063 [Abstract] [Full Text] [Related]
8. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. Noris M, Azzollini N, Pezzotta A, Mister M, Benigni A, Marchetti G, Gagliardini E, Perico N, Remuzzi G. J Am Soc Nephrol; 2001 Sep 27; 12(9):1937-1946. PubMed ID: 11518788 [Abstract] [Full Text] [Related]
10. Recipient hypertension potentiates chronic functional and structural injury of rat renal allografts. Kusaka M, Mackenzie HS, Ziai F, Hancock WW, Tilney NL. Transplantation; 2002 Aug 15; 74(3):307-14. PubMed ID: 12177607 [Abstract] [Full Text] [Related]
11. The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model. Orth SR, Odoni G, Amann K, Strzelczyk P, Raschack M, Ritz E. J Am Soc Nephrol; 1999 Feb 15; 10(2):387-91. PubMed ID: 10215340 [Abstract] [Full Text] [Related]
12. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation. Li J, Basler M, Alvarez G, Brunner T, Kirk CJ, Groettrup M. Kidney Int; 2018 Mar 15; 93(3):670-680. PubMed ID: 29229189 [Abstract] [Full Text] [Related]
13. Protective effects of atorvastatin on chronic allograft nephropathy in rats. Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M. J Surg Res; 2007 Dec 15; 143(2):428-36. PubMed ID: 17628598 [Abstract] [Full Text] [Related]
14. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U. Kidney Int; 2000 Mar 15; 57(3):982-91. PubMed ID: 10720951 [Abstract] [Full Text] [Related]
15. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats. Shimizu T, Hata S, Kuroda T, Mihara S, Fujimoto M. Eur J Pharmacol; 1999 Sep 17; 381(1):39-49. PubMed ID: 10528132 [Abstract] [Full Text] [Related]
16. Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy. Schindler R, Tullius SG, Tanriver Y, Noack K, Qun Y, Jürgensen JS, Frei U. Kidney Int; 2003 Jun 17; 63(6):2302-8. PubMed ID: 12753322 [Abstract] [Full Text] [Related]
17. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts. Pan F, Fisniku O, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K, Kobayashi M, Benediktsson H, Jiang H. Transplant Proc; 2005 Jun 17; 37(1):134-6. PubMed ID: 15808572 [Abstract] [Full Text] [Related]
18. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Song E, Zou H, Yao Y, Proudfoot A, Antus B, Liu S, Jens L, Heemann U. Kidney Int; 2002 Feb 17; 61(2):676-85. PubMed ID: 11849411 [Abstract] [Full Text] [Related]
19. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts. Simonson MS, Herman WH, Robinson A, Schulak J, Hricik DE. Transplantation; 1999 Jun 27; 67(12):1542-7. PubMed ID: 10401760 [Abstract] [Full Text] [Related]
20. Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats. Ohkita M, Wang Y, Nguyen ND, Tsai YH, Williams SC, Wiseman RC, Killen PD, Li S, Yanagisawa M, Gariepy CE. Hypertension; 2005 May 27; 45(5):940-6. PubMed ID: 15809364 [Abstract] [Full Text] [Related] Page: [Next] [New Search]